Moderna shares plunge after leak of cancer vaccine data despite positive results
Moderna's stock fell even though the full data, released later Thursday, appeared positive based on Wall Street expectations ahead of the release.
This is a summary aggregated from CNBC. Read the complete article on the original site:
Read full article at CNBC
